332 related articles for article (PubMed ID: 15732870)
21. Regenerative periodontal therapy of infrabony defects using minimally invasive surgery and a collagen-enriched bovine-derived xenograft: a 1-year prospective study on clinical and aesthetic outcome.
Cosyn J; Cleymaet R; Hanselaer L; De Bruyn H
J Clin Periodontol; 2012 Oct; 39(10):979-86. PubMed ID: 22845338
[TBL] [Abstract][Full Text] [Related]
22. Effect of platelet-rich plasma on the healing of intrabony defects treated with Beta tricalcium phosphate and expanded polytetrafluoroethylene membranes.
Döri F; Huszár T; Nikolidakis D; Tihanyi D; Horváth A; Arweiler NB; Gera I; Sculean A
J Periodontol; 2008 Apr; 79(4):660-9. PubMed ID: 18380559
[TBL] [Abstract][Full Text] [Related]
23. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial.
Zucchelli G; Amore C; Montebugnoli L; De Sanctis M
J Periodontol; 2003 Dec; 74(12):1725-35. PubMed ID: 14974812
[TBL] [Abstract][Full Text] [Related]
24. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
25. Healing of intra-bony defects following treatment with a composite bovine-derived xenograft (Bio-Oss Collagen) in combination with a collagen membrane (Bio-Gide PERIO).
Sculean A; Chiantella GC; Windisch P; Arweiler NB; Brecx M; Gera I
J Clin Periodontol; 2005 Jul; 32(7):720-4. PubMed ID: 15966877
[TBL] [Abstract][Full Text] [Related]
26. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 12-month clinical and radiological study.
Mengel R; Soffner M; Flores-de-Jacoby L
J Periodontol; 2003 Jun; 74(6):899-908. PubMed ID: 12887004
[TBL] [Abstract][Full Text] [Related]
27. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans.
Lekovic V; Camargo PM; Weinlaender M; Nedic M; Aleksic Z; Kenney EB
J Periodontol; 2000 Jul; 71(7):1110-6. PubMed ID: 10960017
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
[TBL] [Abstract][Full Text] [Related]
29. Comparison of porous and non-porous teflon membranes plus a xenograft in the treatment of vertical osseous defects: a clinical reentry study.
Walters SP; Greenwell H; Hill M; Drisko C; Pickman K; Scheetz JP
J Periodontol; 2003 Aug; 74(8):1161-8. PubMed ID: 14514229
[TBL] [Abstract][Full Text] [Related]
30. Comparison of calcium sulfate and autogenous bone graft to bioabsorbable membranes plus autogenous bone graft in the treatment of intrabony periodontal defects: a split-mouth study.
Orsini M; Orsini G; Benlloch D; Aranda JJ; Lazaro P; Sanz M; De Luca M; Piattelli A
J Periodontol; 2001 Mar; 72(3):296-302. PubMed ID: 11327056
[TBL] [Abstract][Full Text] [Related]
31. Factors influencing treatment outcomes in mandibular Class II furcation defects.
Tsao YP; Neiva R; Al-Shammari K; Oh TJ; Wang HL
J Periodontol; 2006 Apr; 77(4):641-6. PubMed ID: 16584345
[TBL] [Abstract][Full Text] [Related]
32. Bioabsorbable membrane and bioactive glass in the treatment of intrabony defects in patients with generalized aggressive periodontitis: results of a 5-year clinical and radiological study.
Mengel R; Schreiber D; Flores-de-Jacoby L
J Periodontol; 2006 Oct; 77(10):1781-7. PubMed ID: 17032123
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes following treatment of human intrabony defects with GTR/bone replacement material or access flap alone. A multicenter randomized controlled clinical trial.
Tonetti MS; Cortellini P; Lang NP; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Rasperini G; Rossi R; Silvestri M; Topoll H; Wallkamm B; Zybutz M
J Clin Periodontol; 2004 Sep; 31(9):770-6. PubMed ID: 15312100
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of an enamel matrix protein derivative (Emdogain) combined with a bovine-derived xenograft (Bio-Oss) for the treatment of intrabony periodontal defects in humans.
Sculean A; Chiantella GC; Windisch P; Gera I; Reich E
Int J Periodontics Restorative Dent; 2002 Jun; 22(3):259-67. PubMed ID: 12186348
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive effect of a polylactide/polyglycolide copolymer in the treatment of deep periodontal intra-osseous defects: a randomized clinical trial.
Minenna L; Herrero F; Sanz M; Trombelli L
J Clin Periodontol; 2005 May; 32(5):456-61. PubMed ID: 15842259
[TBL] [Abstract][Full Text] [Related]
36. Treatment of intrabony periodontal defects with platelet-rich plasma versus platelet-poor plasma combined with a bovine-derived xenograft: a controlled clinical trial.
Yilmaz S; Kabadayi C; Ipci SD; Cakar G; Kuru B
J Periodontol; 2011 Jun; 82(6):837-44. PubMed ID: 21138357
[TBL] [Abstract][Full Text] [Related]
37. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a collagen membrane with and without bone grafts in treating periodontal intrabony defects.
Chen CC; Wang HL; Smith F; Glickman GN; Shyr Y; O'Neal RB
J Periodontol; 1995 Oct; 66(10):838-47. PubMed ID: 8537865
[TBL] [Abstract][Full Text] [Related]
39. Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects.
Pradeep AR; Shetty SK; Garg G; Pai S
J Periodontol; 2009 Jan; 80(1):62-71. PubMed ID: 19228091
[TBL] [Abstract][Full Text] [Related]
40. Guided tissue regeneration associated with bovine-derived anorganic bone in mandibular class II furcation defects. 6-month results at re-entry.
Simonpietri-C JJ; Novaes AB; Batista EL; Filho EJ
J Periodontol; 2000 Jun; 71(6):904-11. PubMed ID: 10914793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
